Activated PI3 kinase delta syndrome

DBCOND0156285Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesImmune System Diseases

Activated PI3 kinase delta syndrome is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Activated PI3K-delta Syndrome · Activated PI3Kdelta Syndrome APDS · Activated PI3K Delta Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0590464SNOMED CT711480000MedDRA10078281UMLSC3714976

What you can answer from here — as of October 24, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Activated PI3 kinase delta syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In